Would that be the top pick of 2020 ? Exelixis shows strong balance sheet plus the growth potential from further expansion.
Stock Mover
- Exelixis Further Expands Prostate Cancer Cohort in Phase 1b
- Exelixis to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
What do you guys think ?
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。